Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China

doi:10.3748/wjg.14.2715

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 17

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3720)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

457

HTML

2824

Figures (1-3)

203

Tables (1-5)

236

Sum=3720

May 7, 2008 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (30)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. May 7, 2008; 14(17): 2715-2722
Published online May 7, 2008. doi: 10.3748/wjg.14.2715

Table 3 Accumulated and synthesized data

Regimens	Accumulated	Synthesized	Accumulated	Synthesized
	n	MST (mo)	CR+PR (%)	DMC¹ (￥, RMB)
5FU+ADM/EPI+MMC (FAM)	84	10.8	38.1	1978.23
5FU+VP-16+CF(ELF)	45	11.7	53.3	2543.12
5FU+CF+DDP+MMC (LFP/M)	91	9.0	44.0	3056.08
5FU+CF+ADM+MTX (FAMTX)	UR	6.1	21.0	1756.95
5FU+EPI+DDP (ECF)	UR	8.7	44.4²	2276.43²
5FU+DDP+PTX (TCF)	22	UR	50.0	2667.01
5FU+CF+DXL+DDP (DCF)	32	UR	56.3	9979.00
5FU+CF+L-OHP (FOLFOX)	60	UR	50.0	3244.31
UFT+MMC (UFTM)	49	8.5	32.7	2441.29
UFT+DDP+VP-16(FEP)	51	10.0	47.1	1999.97
DDP+VP-16+ADM/EPI (EAP)	40	8.5	52.5	2790.23

¹All the cost data were converted to 2007 price by preset discount rate (1%);

²The data were synthesized by giving the weights equal to those of the studies (Table 1). CR: Complete response; PR: Partial response; MST: Median survival time; DMC: Per capita direct medical cost of single cycle; 5FU: 5-fluorouracil; ADM: Adriamycin; EPI: Epirubicin; MMC: Mitomycin; DDP: Cisplatin; VP-16: Etoposide; CF: Calcium Leucovorin; UFT: Uracil-tegafur; MTX: Methotrexate; PTX: Paclitaxel; DXL: Docetaxel; L-OHP: Oxaliplatin; UR: Unretrieved data.

Citation: Chen XZ, Jiang K, Hu JK, Zhang B, Gou HF, Yang K, Chen ZX, Chen JP. Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China. World J Gastroenterol 2008; 14(17): 2715-2722
URL: https://www.wjgnet.com/1007-9327/full/v14/i17/2715.htm
DOI: https://dx.doi.org/10.3748/wjg.14.2715